Skip to main content
Top
Published in: Journal of Neurology 10/2012

01-10-2012 | Original Communication

In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques

Authors: Michaela A. Seigo, Elias S. Sotirchos, Scott Newsome, Aleksandra Babiarz, Christopher Eckstein, E’Tona Ford, Jonathan D. Oakley, Stephanie B. Syc, Teresa C. Frohman, John N. Ratchford, Laura J. Balcer, Elliot M. Frohman, Peter A. Calabresi, Shiv Saidha

Published in: Journal of Neurology | Issue 10/2012

Login to get access

Abstract

Macular optical coherence tomography (OCT) segmentation, enabling quantification of retinal axonal and neuronal subpopulations, may help elucidate the neuroretinal pathobiology of multiple sclerosis (MS). This study aimed to determine the agreement, reproducibility, and visual correlations of retinal layer thicknesses measured by different OCT segmentation techniques, on two spectral-domain OCT devices. Macular scans of 52 MS patients and 30 healthy controls from Spectralis OCT and Cirrus HD-OCT were segmented using fully manual (Spectralis), computer-aided manual (Spectralis and Cirrus), and fully automated (Cirrus) segmentation techniques. Letter acuity was recorded. Bland-Altman analyses revealed low mean differences across OCT segmentation techniques on both devices for ganglion cell + inner plexiform layers (GCIP; 0.76–2.43 μm), inner nuclear + outer plexiform layers (INL + OPL; 0.36–1.04 μm), and outer nuclear layers including photoreceptor segment (ONL + PR; 1.29–3.52 μm) thicknesses. Limits of agreement for GCIP and ONL + PR thicknesses were narrow. Results of fully manual and computer-aided manual segmentation were comparable to those of fully automated segmentation. MS patients demonstrated macular RNFL, GCIP, and ONL + PR thinning compared to healthy controls across OCT segmentation techniques, irrespective of device (p < 0.03 for all). Low-contrast letter acuity in MS correlated significantly and more strongly with GCIP than peripapillary RNFL thicknesses, regardless of the segmentation method or device. GCIP and ONL + PR thicknesses, measured by different OCT devices and segmentation techniques, are reproducible and agree at the individual and cohort levels. GCIP thinning in MS correlates with visual dysfunction. Significant ONL + PR thinning, detectable across OCT segmentation techniques and devices, strongly supports ONL pathology in MS. Fully automated, fully manual and computer-assisted manual OCT segmentation techniques compare closely, highlighting the utility of accurate and time-efficient automated segmentation outcomes in MS clinical trials.
Appendix
Available only for authorised users
Literature
1.
go back to reference Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254(5035):1178–1181PubMedCrossRef Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254(5035):1178–1181PubMedCrossRef
2.
go back to reference Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–675PubMedCrossRef Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–675PubMedCrossRef
3.
go back to reference Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA (2008) Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol 65(9):1218–1222PubMedCrossRef Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA (2008) Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol 65(9):1218–1222PubMedCrossRef
4.
go back to reference Syc SB, Warner CV, Hiremath GS, Farrell SK, Ratchford JN, Conger A, Frohman T, Cutter G, Balcer LJ, Frohman EM, Calabresi PA (2010) Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler 16(7):829–839PubMedCrossRef Syc SB, Warner CV, Hiremath GS, Farrell SK, Ratchford JN, Conger A, Frohman T, Cutter G, Balcer LJ, Frohman EM, Calabresi PA (2010) Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler 16(7):829–839PubMedCrossRef
5.
go back to reference Chen TC, Cense B, Pierce MC, Nassif N, Park BH, Yun SH, White BR, Bouma BE, Tearney GJ, de Boer JF (2005) Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 123(12):1715–1720PubMedCrossRef Chen TC, Cense B, Pierce MC, Nassif N, Park BH, Yun SH, White BR, Bouma BE, Tearney GJ, de Boer JF (2005) Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 123(12):1715–1720PubMedCrossRef
6.
go back to reference Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M, Rothenbuehler SP, Enzmann V, Wolf S (2009) Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 50(7):3432–3437PubMedCrossRef Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M, Rothenbuehler SP, Enzmann V, Wolf S (2009) Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 50(7):3432–3437PubMedCrossRef
8.
go back to reference Sisto D, Trojano M, Vetrugno M, Trabucco T, Iliceto G, Sborgia C (2005) Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci 46(4):1264–1268PubMedCrossRef Sisto D, Trojano M, Vetrugno M, Trabucco T, Iliceto G, Sborgia C (2005) Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci 46(4):1264–1268PubMedCrossRef
9.
go back to reference Toussaint D, Perier O, Verstappen A, Bervoets S (1983) Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 3(3):211–220PubMed Toussaint D, Perier O, Verstappen A, Bervoets S (1983) Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 3(3):211–220PubMed
10.
go back to reference Ikuta F, Zimmerman HM (1976) Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 26(6 PT 2):26–28PubMedCrossRef Ikuta F, Zimmerman HM (1976) Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 26(6 PT 2):26–28PubMedCrossRef
11.
go back to reference Shindler KS, Ventura E, Dutt M, Rostami A (2008) Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res 87(3):208–213PubMedCrossRef Shindler KS, Ventura E, Dutt M, Rostami A (2008) Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res 87(3):208–213PubMedCrossRef
12.
go back to reference Saidha S, Eckstein C, Ratchford JN (2010) Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML Mult Scler 2(2):33–43 Saidha S, Eckstein C, Ratchford JN (2010) Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML Mult Scler 2(2):33–43
13.
go back to reference Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, Oakley JD, Durbin MK, Meyer SA, Balcer LJ, Frohman EM, Rosenzweig JM, Newsome SD, Ratchford JN, Nguyen QD, Calabresi PA (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134(Pt 2):518–533PubMedCrossRef Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, Oakley JD, Durbin MK, Meyer SA, Balcer LJ, Frohman EM, Rosenzweig JM, Newsome SD, Ratchford JN, Nguyen QD, Calabresi PA (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134(Pt 2):518–533PubMedCrossRef
14.
go back to reference Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler J 17(12):1449–1463CrossRef Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler J 17(12):1449–1463CrossRef
15.
go back to reference Davies EC, Galetta KM, Sackel DJ, Talman LS, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ (2011) Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol 31:260–264PubMedCrossRef Davies EC, Galetta KM, Sackel DJ, Talman LS, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ (2011) Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol 31:260–264PubMedCrossRef
16.
go back to reference Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133(Pt 6):1591–1601PubMedCrossRef Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133(Pt 6):1591–1601PubMedCrossRef
17.
go back to reference Papakostopoulos D, Fotiou F, Hart JC, Banerji NK (1989) The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol 74(1):1–10PubMedCrossRef Papakostopoulos D, Fotiou F, Hart JC, Banerji NK (1989) The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol 74(1):1–10PubMedCrossRef
18.
go back to reference Forooghian F, Sproule M, Westall C, Gordon L, Jirawuthiworavong G, Shimazaki K, O’Connor P (2006) Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol 113(2):123–132PubMedCrossRef Forooghian F, Sproule M, Westall C, Gordon L, Jirawuthiworavong G, Shimazaki K, O’Connor P (2006) Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol 113(2):123–132PubMedCrossRef
19.
go back to reference Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846PubMedCrossRef Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846PubMedCrossRef
20.
go back to reference Warner CV, Syc SB, Stankiewicz AM, Hiremath G, Farrell SK, Crainiceanu CM, Conger A, Frohman TC, Bisker ER, Balcer LJ, Frohman EM, Calabresi PA, Saidha S (2011) The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One 6(8):e22947PubMedCrossRef Warner CV, Syc SB, Stankiewicz AM, Hiremath G, Farrell SK, Crainiceanu CM, Conger A, Frohman TC, Bisker ER, Balcer LJ, Frohman EM, Calabresi PA, Saidha S (2011) The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One 6(8):e22947PubMedCrossRef
21.
go back to reference Hood DC, Lin CE, Lazow MA, Locke KG, Zhang X, Birch DG (2009) Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography. Invest Ophthalmol Vis Sci 50(5):2328–2336PubMedCrossRef Hood DC, Lin CE, Lazow MA, Locke KG, Zhang X, Birch DG (2009) Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography. Invest Ophthalmol Vis Sci 50(5):2328–2336PubMedCrossRef
22.
go back to reference Hood DC, Cho J, Raza AS, Dale EA, Wang M (2011) Reliability of a computer-aided manual procedure for segmenting optical coherence tomography scans. Optom Vis Sci 88(1):113–123PubMedCrossRef Hood DC, Cho J, Raza AS, Dale EA, Wang M (2011) Reliability of a computer-aided manual procedure for segmenting optical coherence tomography scans. Optom Vis Sci 88(1):113–123PubMedCrossRef
23.
go back to reference Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310PubMedCrossRef Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310PubMedCrossRef
24.
go back to reference Filippi M, van Waesberghe JH, Horsfield MA, Bressi S, Gasperini C, Yousry TA, Gawne-Cain ML, Morrissey SP, Rocca MA, Barkhof F, Lycklama a Nijeholt GJ, Bastianello S, Miller DH (1997) Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials. Neurology 49(2):371–377PubMedCrossRef Filippi M, van Waesberghe JH, Horsfield MA, Bressi S, Gasperini C, Yousry TA, Gawne-Cain ML, Morrissey SP, Rocca MA, Barkhof F, Lycklama a Nijeholt GJ, Bastianello S, Miller DH (1997) Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials. Neurology 49(2):371–377PubMedCrossRef
25.
go back to reference Filippi M, Rocca MA, Gasperini C, Sormani MP, Bastianello S, Horsfield MA, Pozzilli C, Comi G (1999) Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences. Am J Neuroradiol 20(1):133–137PubMed Filippi M, Rocca MA, Gasperini C, Sormani MP, Bastianello S, Horsfield MA, Pozzilli C, Comi G (1999) Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences. Am J Neuroradiol 20(1):133–137PubMed
26.
go back to reference Lee J, Koh D, Ong CN (1989) Statistical evaluation of agreement between two methods for measuring a quantitative variable. Comput Biol Med 19(1):61–70PubMedCrossRef Lee J, Koh D, Ong CN (1989) Statistical evaluation of agreement between two methods for measuring a quantitative variable. Comput Biol Med 19(1):61–70PubMedCrossRef
27.
go back to reference Kerrison JB, Flynn T, Green WR (1994) Retinal pathologic changes in multiple sclerosis. Retina 14(5):445–451PubMedCrossRef Kerrison JB, Flynn T, Green WR (1994) Retinal pathologic changes in multiple sclerosis. Retina 14(5):445–451PubMedCrossRef
28.
go back to reference Balcer LJ, Galetta SL, Calabresi PA, Confavreux C, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Miller DH, O’Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA (2007) Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology 68(16):1299–1304PubMedCrossRef Balcer LJ, Galetta SL, Calabresi PA, Confavreux C, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Miller DH, O’Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA (2007) Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology 68(16):1299–1304PubMedCrossRef
29.
go back to reference Balcer LJ, Frohman EM (2010) Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology 74(Suppl 3):S16–S23PubMed Balcer LJ, Frohman EM (2010) Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology 74(Suppl 3):S16–S23PubMed
30.
go back to reference Hogan MJ, Alvarado JA, Weddell JE (1971) Histology of the human eye. W. B. Saunders, Philadelphia Hogan MJ, Alvarado JA, Weddell JE (1971) Histology of the human eye. W. B. Saunders, Philadelphia
31.
go back to reference Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67(6):749–760PubMed Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67(6):749–760PubMed
32.
go back to reference Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 69(16):1603–1609PubMedCrossRef Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 69(16):1603–1609PubMedCrossRef
Metadata
Title
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques
Authors
Michaela A. Seigo
Elias S. Sotirchos
Scott Newsome
Aleksandra Babiarz
Christopher Eckstein
E’Tona Ford
Jonathan D. Oakley
Stephanie B. Syc
Teresa C. Frohman
John N. Ratchford
Laura J. Balcer
Elliot M. Frohman
Peter A. Calabresi
Shiv Saidha
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 10/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6466-x

Other articles of this Issue 10/2012

Journal of Neurology 10/2012 Go to the issue